Out-licensing
Innovative out-licensing products for pharma partners around the globe.
Excellence in advanced drug delivery and fully integrated services – everything from a single source, from us.
Excellent Swiss-quality products
Everything from a single source, from us
Excellent Swiss-quality products
Acino develops and manufactures high quality medicinal products with established active ingredients in advanced and refined drug delivery systems. We supply leading pharmaceutical and generics companies around the globe.
Everything from a single source, from us
We go beyond products and offer fully integrated services including drug regulatory services and product supply. We can support you, from sourcing of an active pharmaceutical ingredient to finished product.
Market-ready Licensing Products
Acino is a Swiss-based company that develops and manufactures high quality medicinal products with established active ingredients in advanced and refined drug delivery systems. New products are continually being developed and added to our extensive range.
The following products, which are either already marketed or in registration, are currently available for out-licensing:
Active ingredient | Formulation | Dosage strength |
Acino assembles complete registration dossiers and offers for all products a Common Technical Document (CTD). | ||
Alfuzosine G04CA01 |
Retard tablet | 5 / 10 mg |
Amlodipine C08CA01 |
Tablet | 5 / 10 mg |
Clopidogrel B01AC04 |
Film tablet | 75 mg |
Doxazosine C02CA04 |
Retard tablet | 4 / 8 mg |
Itraconazole J02AC02 |
Capsule | 100 mg |
Metoprolol succinate C07AB02 |
Once-daily retard tablet | 23.75 / 47.5 / 95 / 190 mg |
Nebivolol AC07AB12 |
Tablet | 5 mg |
Oxycodone N02AA05 |
Retard tablet | 5 / 10 / 20 / 30 / 40 / 60 / 80 mg |
On July 25, 2016, Acino International AG and Acino Pharma AG (together “Acino”) signed an agreement to divest Acino’s transdermal patch and implant business to Luye Pharma Group Ltd. (“Luye”). The divestment includes Acino’s transdermal manufacturing operations, distribution, and R&D capabilities. Closing of this deal is expected before the end of 2016.
Acino will retain the marketing rights to certain transdermal patches in its strategic emerging markets.
Disclaimer
Brand names/trademarks might be subject to local/regional adaption. Indication for use might differ due to local requirements/registration. Indications given in this table are based on the respective underlying CH or EU marketing authorizations.
Services
Acino offers fully integrated services. Whether you opt for the entire service chain or have individual needs, we provide top-quality work, something every customer can rightfully expect from us.
Sourcing
Acino Sourcing Network
Sourcing of APIs, excipients, packaging materials
Worldwide networkensuring competitive costs and complianceDevelopment
Acino Technology Competence And R&D Centers
Development of solid oral forms
acinoRegistration
Acino Regulatory Affairs Team
Compilation of dossiers ready for submission worldwide
Manufacturing
Acino Production Sites
Manufacturing of finished dosage form
↓
Supply of bulk productPackaging
Acino Packaging Facilities
Primary & secondary packaging
↓
Supply of finished product
acino with customers
Regulatory Services
Our drug regulatory experts have a broad-based knowledge of the regulatory requirements for the different products and indications and know the local regulatory requirements around the globe inside out.
From early development, we provide regulatory advice throughout the commercial life of a product. We support contract partners in the provision of regulatory relevant documentation, ensure regulatory compliance for all products on the market and provide regulatory intelligence services.
Our specific expertise includes:
- Design of regulatory strategies, starting from the inception of a new product idea
- Provision and assembly of complete registration dossiers for all development and marketed products
- Worldwide submission and registration
Product Supply
Different product characteristics and galenical forms require different packaging. Even more complex are the requirements of our customers when it comes to tailor-made product packaging, be it in bulk or medicine packaged in their final packaging for distribution to patients.
Managing the supply chain with a large variety of pack sizes, country-specific labeling and patient information in different languages is a well-established logistics task for our experienced team. Providing these services with the accustomed indisputable quality is a matter of course for our customers, and rounds off our service offering.
We package in numerous variations, the most widely used ones are:
- bulk
- blisters with foil (PP, Aclar, childproof foils, etc.) and alu-alu-blisters
- alu-alu-strip packaging
- sachets
- stick packs
Our logistics facility for oral drugs in Aesch (Switzerland) is equipped with state-of-the-art packaging lines and a fully automated high bay warehouse with 8000 pallet racks.
Contacts
Out-Licensing
Timo Taghizadeh
Head of Out-Licensing and Contract Manufacturing
Telefon +41 44 555 22 62
EmailGeneral enquiries
Acino International AG
Thurgauerstrasse 36/38
CH-8050 Zurich
Telefon +41 44 555 22 00
Email